Justin J. Juliano, M.D.

Radiation Oncology

Brachytherapy Gynecologic Cancers Genitourinary Cancers

Dr. Juliano was born in Saratoga Springs, NY. He completed his medical training at SUNY Upstate Medical Center in Syracuse, NY, in 2002. He then went on to complete radiation oncology residency training at Cleveland Clinic in June 2007. Dr. Juliano subsequently joined the Cleveland Clinic staff pursuing his interest in gynecologic malignancy as well as high dose rate brachytherapy for a wide range of malignancies. He joined Hershey Medical Center in April 2010 and will continue his interest in brachytherapy and gynecologic malignancy. In addition, he will expand his clinical service to genitourinary malignancies. In the future, Dr. Juliano will look to develop a hyperthermia program to complement his services in radiotherapy.

Residency, Radiation Oncology, Cleveland Clinic Foundation (Ohio) (2007) Residency, Radiation Oncology, Hahnemann University Hospital (Pennsylvania) (2004) Internship, Transitional, Mary Imogene Bassett Hospital (New York) (2003) M.D., SUNY Upstate University, Syracuse College of Medicine (2002)

Image guided brachytherapy
Image guided radiotherapy
Hyperthermia

Sheplan LS, Juliano JJ
Use of radiation therapy for patients with soft-tissue and bone sarcomas.
Cleveland Clinic Journal of Medicine. 2010 Mar; 77Suppl, 1:S27-9. Juliano JJ, Cody RL, Suh JH
Metastatic adrenocortical oncocytoma: A case report.
Urologic Oncology. 2008 Mar-Apr; 26(2):198-201. Juliano JJ, Reddy CA, Videtic GMM
How fast does practice change? A single-institution experience in utilization of a single fraction for palliation of bone metastases before and after RTOG 9714.
(in preparation) Juliano JJ, Bauer TW, Barnett GH, Suh JH
Successful treatment of giant cell tumor of the jugular foramen with Gamma Knife radiosurgery.
(in preparation) Juliano JJ, Mekhail TM, Rice TW, Murthy SC, Mason DP, Adelstein DJ, Suh JH, Reddy CA, Videtic GMM
Comprehensive mediastinal nodal characterization optimizes outcome prediction: Results from a single-institution trimodality regimen in mediastinoscopy-defined stage III non-small cell lung cancer (NSCLC)
(in preparation)